[Serum glucose and immunoreactive insulin during or without treatment with Th 1165a und Isoptin in gravid women (author's transl)].
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood*; D009921:Metaproterenol / Q000009:adverse effects* / Q000494:pharmacology; D009765:Obesity / Q000378:metabolism; D010276:Parasympatholytics / Q000009:adverse effects* / Q000494:pharmacology; D010636:Phenols / Q000009:adverse effects / Q000494:pharmacology; D011247:Pregnancy; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D001786:Blood Glucose; D007328:Insulin; D010276:Parasympatholytics; D010636:Phenols; D009921:Metaproterenol; D014700:Verapamil; D005947:Glucose
Blutglukose und Immunoreaktives Insulin unter dem Einflubb von Th 1165a und Isoptin bei Schwangeren mit und ohne tokolytische Therapie.